Solid Biosciences Inc. SLDB Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Solid Biosciences Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Solid Biosciences Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Solid Biosciences Inc.'s operating income?
- Solid Biosciences Inc. (SLDB) reported operating income of -$57.31M in Q1 2026.
- How has Solid Biosciences Inc.'s operating income changed year-over-year?
- Solid Biosciences Inc.'s operating income decreased by 43.1% year-over-year, from -$40.05M to -$57.31M.
- What is the long-term trend for Solid Biosciences Inc.'s operating income?
- Over 4 years (2021 to 2025), Solid Biosciences Inc.'s operating income has grown at a 25.5% compound annual growth rate (CAGR), from -$72.25M to -$179.21M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.